Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
March 17th, 2023
The protocol summarizes the best practices to minimize microbial bioburden in a cleanroom environment and includes strategies such as environmental monitoring, process monitoring, and product sterility testing. It is relevant for manufacturing and testing facilities that are required to meet current good tissue practice standards and current good manufacturing practice standards.
Clinical microbiology labs are being increasingly asked to assist with sterility testing as cellular therapies emerge as frontline treatment options. This project aims to provide clear instructions for implementing microbial monitoring and testing strategies applicable to any CGMP setting with a particular focus on academic and clinical laboratories. Gold standard microbial testing and CGMP relies on traditional culture-based methods, which are slow.
While newer technologies exist, implementation is often limited by the regulatory requirement to conduct rigorous end-user validations to demonstrate non-inferiority. We hope that future work will help establish newer technologies into the mainstream for CGMP testing. There is no standardization between programs in CGMP.
While a regulatory framework is provided, microbial monitoring and testing strategies are unique to each facility and rely on a risk-based approach and end-user validation. This can be confusing for establishing new CGMP programs in the clinical setting. Our group aims to bring awareness of CGMP to the clinical setting.
We have published large-scale studies highlighting the advantages and pitfalls of blood culture systems for sterility testing as well as review articles demonstrating major differences between the clinical and CGMP microbiology labs and areas for consideration if implementing sterility testing in the clinical setting.
View the full transcript and gain access to thousands of scientific videos
Overview
This protocol outlines best practices to minimize microbial bioburden in cleanroom environments, focusing on environmental and process monitoring, as well as product sterility testing. It is particularly relevant for facilities adhering to current good tissue practice and current good manufacturing practice standards.
Key Study Components
Area of Science
- Microbial monitoring
- Sterility testing
- Good manufacturing practices
Background
- Clinical microbiology labs are increasingly involved in sterility testing.
- Cellular therapies are becoming frontline treatment options.
- Traditional culture-based methods for microbial testing are slow.
- Regulatory requirements hinder the adoption of newer technologies.
Purpose of Study
- To provide clear instructions for microbial monitoring in CGMP settings.
- To focus on academic and clinical laboratories.
- To establish newer technologies into mainstream CGMP testing.
Methods Used
- Environmental monitoring techniques.
- Process monitoring strategies.
- Product sterility testing protocols.
- Implementation of traditional culture-based methods.
Main Results
- Clear instructions for microbial monitoring were developed.
- Challenges in standardization between CGMP programs were identified.
- Future work is needed to integrate newer technologies.
Conclusions
- Microbial monitoring is crucial in CGMP settings.
- There is a need for improved methodologies in sterility testing.
- Collaboration between labs can enhance standardization efforts.
